We are live on ! Find out more
BCAM

Boston Common Asset Management Portfolio holdings

AUM $1.69B
1-Year Est. Return 28.29%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+28.29%
3 Year Est. Return
+54.94%
5 Year Est. Return
+54.02%
10 Year Est. Return
+260.31%
AUM
$3.57B
AUM Growth
+$273M
Cap. Flow
-$19.8M
Cap. Flow %
-0.56%
Top 10 Hldgs %
15.41%
Holding
325
New
35
Increased
82
Reduced
162
Closed
28

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$12.9M
2
CRM icon
Salesforce
CRM
+$9.6M
3
TSM icon
TSMC
TSM
+$9.22M
4
KLAC icon
KLA
KLAC
+$7.93M
5
LLY icon
Eli Lilly
LLY
+$6.58M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$17.3M
2
HOLX
Hologic
HOLX
+$16.8M
3
MU icon
Micron Technology
MU
+$10M
4
ZBH icon
Zimmer Biomet
ZBH
+$6.83M
5
BALL icon
Ball Corp
BALL
+$6.55M

Sector Composition

Rank Sector Weight
1 Technology 13.67%
2 Financials 8.72%
3 Healthcare 5.78%
4 Communication Services 4.95%
5 Industrials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMP icon
26
Ameriprise Financial
AMP
$48.3B
$20.3M 0.57%
38,052
-1,563
-4% -$772K
PG icon
27
Procter & Gamble
PG
$336B
$20.3M 0.57%
127,284
-34,040
-21% -$5.56M
VRT icon
28
Vertiv
VRT
$93B
$19.6M 0.55%
152,952
-20,814
-12% -$2.02M
CARR icon
29
Carrier Global
CARR
$51B
$18.7M 0.53%
256,127
-32,142
-11% -$2.18M
INTU icon
30
Intuit
INTU
$86.5B
$18.5M 0.52%
23,471
-599
-2% -$405K
DHR icon
31
Danaher
DHR
$137B
$17.4M 0.49%
87,844
-2,973
-3% -$577K
NVS icon
32
Novartis
NVS
$297B
$16.8M 0.47%
138,583
-11,877
-8% -$1.34M
EMR icon
33
Emerson Electric
EMR
$83.9B
$16.4M 0.46%
122,805
-33,241
-21% -$3.81M
XYL icon
34
Xylem
XYL
$27.3B
$16.2M 0.45%
125,029
-2,328
-2% -$282K
SAP icon
35
SAP
SAP
$212B
$15.3M 0.43%
50,300
-3,634
-7% -$1.04M
MELI icon
36
Mercado Libre
MELI
$95.2B
$15.3M 0.43%
5,837
+1,171
+25% +$2.73M
ECL icon
37
Ecolab
ECL
$78.1B
$14.7M 0.41%
54,382
-2,044
-4% -$520K
MET icon
38
MetLife
MET
$61.9B
$14.3M 0.4%
177,887
-39,706
-18% -$3.06M
CME icon
39
CME Group
CME
$96.3B
$13.7M 0.38%
49,598
+17,222
+53% +$4.68M
DLR icon
40
Digital Realty Trust
DLR
$69.7B
$13.6M 0.38%
78,242
+13,014
+20% +$2.13M
COST icon
41
Costco
COST
$422B
$13.5M 0.38%
13,676
-488
-3% -$485K
GILD icon
42
Gilead Sciences
GILD
$162B
$13.5M 0.38%
122,085
-11,043
-8% -$1.18M
DGX icon
43
Quest Diagnostics
DGX
$25.7B
$13.3M 0.37%
+74,250
New +$12.9M
AMGN icon
44
Amgen
AMGN
$208B
$13.3M 0.37%
47,460
-2,255
-5% -$639K
UL icon
45
Unilever
UL
$137B
$13.1M 0.37%
190,364
+3,363
+2% +$236K
SW
46
Smurfit Westrock
SW
$24.1B
$13M 0.36%
300,134
-92,501
-24% -$3.96M
FITB
47
Fifth Third Bancorp
FITB
$51.2B
$12.5M 0.35%
303,355
+7,398
+2% +$278K
AON icon
48
Aon
AON
$76.5B
$12.4M 0.35%
34,833
+8,394
+32% +$3.04M
BAC icon
49
Bank of America
BAC
$435B
$12.3M 0.34%
259,680
+24,740
+11% +$1.04M
DAI
50
DELISTED
DAIMLER AG
DAI
$12.3M 0.34%
210,357
-14,147
-6% -$825K
1
2
3 4 5

Similar funds

GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return
BA
Bridgewater Advisors New York $1.68B AUM 20.28% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

Boston Common Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Boston Common Asset Management held 325 positions worth $3.57B, up 8.3% from $3.29B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boston Common Asset Management's Q2 2025 filing shows 35 new, 82 increased, 162 reduced and 28 closed positions. Its largest new stake was Quest Diagnostics: 74,250 shares worth $13.3M. The largest sale was Regeneron Pharmaceuticals, an estimated $17.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • Boston Common Asset Management's largest Q2 2025 buy was Quest Diagnostics: 74,250 shares worth $13.3M.
  • Boston Common Asset Management added most to Salesforce in Q2 2025, an estimated $9.6M increase.
  • Boston Common Asset Management's biggest Q2 2025 reduction was Micron Technology, cutting an estimated $10M.
  • Boston Common Asset Management fully exited Regeneron Pharmaceuticals in Q2 2025, selling an estimated $17.3M.
  • Boston Common Asset Management's ten largest holdings make up 15% of its $3.57B portfolio in Q2 2025.
  • Boston Common Asset Management opened 35 new positions and closed 28 in Q2 2025.
  • Boston Common Asset Management's portfolio value rose 8.3% quarter-over-quarter to $3.57B.

Based on Boston Common Asset Management's 13F filing for Q2 2025, filed 22 Jul 2025.